2 Marijuana Stocks To Watch As More Momentum Enters The Cannabis Sector

With marijuana stocks finally catching a wave of upward momentum investors want to know how long this will last. Now there is no way to be 100 percent certain how long this momentum will last. However with earnings soon to be reported by various cannabis companies some marijuana stocks may continue to rise. Shareholders have been waiting to see a rise in trading ever since mid-February when many cannabis stocks started to drop in the market.

2020 is a year we’ll never forget. How could we? If 2020 was a story, then the COVID-19 pandemic would be the main antagonist. It upended everything, reorienting the economy, business operations, and our own livelihoods.

The pathway to the U.S. cannabis market is being watched closely by Canadian companies eager to enter the frenzied space. But an already well-trodden path exists for those companies seeking an early advantage over their Canadian peers - CBD. 

As the U.S. cannabis market remains closed due to the drug still illegal federally, although more than half of the country's states have passed measures allowing its sale for either medical or recreational purposes, Canadian companies have begun to move in earnest to establish a U.S. presence but solely in the CBD space. 

The Ontario Cannabis Store (OCS) will accept fewer incoming deliveries from the country's pot producers this month to help curtail the spread of COVID-19, a move that could lead to a steep revenue hit for cannabis companies dependent on sales in the country's biggest consumer market. 

"Like all operators in the retail sector, necessary public health measures in our warehouse facility to manage COVID-19 and keep workers as safe as possible have reduced the speed with which we are able to receive new deliveries from our licensed producer partners," said Daffyd Roderick, senior director of communications at the OCS, in an emailed statement. 

Cannabis consumers, especially newcomers hoping to find a cure for their specific condition, should manage their expectations when using this plant.

It is safe to say by now that most of those who follow the what’s what in the grand scheme of the marijuana movement have encountered just about every fathomable medical claim associated with cannabis. All one needs to do is get into a quick Google search to find several sources suggesting that medical marijuana is useful in the treatment of severe health conditions from Alzheimer’s disease to pain.

At times, marijuana stocks have the ability to be the best-performing stocks in the market. They can catch fire — no pun intended — on headlines or reports and scorch higher. During some of these runs, it’s not odd to see the stocks double or triple in value over a short period of time.

A high level of short interest also helps spark a nice move. In other words, bears put on a number bets to the downside, shorting these stocks as they look for a big move lower. Oftentimes, these bears get exactly what they’re looking for, as marijuana stocks tend to be a volatile bunch.

However, sometimes these bets backfire.

Here are three strategies for cannabis companies to avoid drawn out regulatory investigations and to decrease the risk of facing regulatory penalties. Those penalties could include significant fines, license suspension or, in a worst-case scenario, license revocation.

1. Develop an expertise in your company’s security measures

Often, what causes a cannabis company trouble are the “unknown unknowns” of the business operation or, another way to put it, the “blind spots.” While it is easy to observe strategic errors in a competitor, a company generally has trouble seeing its own until it’s too late, which can be costly. To counter this, get another set of eyes on the operation with an objective viewpoint.

Reliable security experts can:

If it weren’t for cannabidiol, more commonly known as CBD, the marijuana industry would be on the streets begging for nickels rather than enjoying the fruits of a business sector that is predicted to be worth $22 billion within the next few years.

It seems that America has fully embraced the concept of this non-intoxicating cannabinoid in hopes that it will do everything its proponents say it will, from alleviating pain, anxiety and perhaps even depression. But due to the company this marketplace keeps — not to mention its lack of federal oversight — a lot of consumers are snatching up CBD products that may not be all they’re cracked up to be. These are just a few of the most common problems with all that CBD the nation has become so smitten with.

Today is a big day for the cannabis industry as Tilray, Inc. (TLRY) shareholders are going to attend a special shareholder meeting to vote on previously announced mega-merger with Aphria, Inc. (APHA.TO) (APHA).

We expect Tilray shareholders to vote in favor of the merger and believe that the combined company will be the world’s largest cannabis company. Earlier this month, Tilray passed changes to make it easier for it to meet the requirements that are needed to reach quorum at the special meeting.